2008
DOI: 10.1007/s15010-008-7236-7
|View full text |Cite
|
Sign up to set email alerts
|

Successful Long-Term Treatment with Linezolid for Disseminated Infection with Multiresistant Nocardia farcinica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 21 publications
0
17
0
Order By: Relevance
“…sual impairment have been reported (11)(12)(13). In our patient, linezolid was excluded, based on the risk of myelotoxicity.…”
Section: Case Reportmentioning
confidence: 95%
“…sual impairment have been reported (11)(12)(13). In our patient, linezolid was excluded, based on the risk of myelotoxicity.…”
Section: Case Reportmentioning
confidence: 95%
“…Antimicrobial sensitivity testing has shown that it has excellent activity against all species of Nocardia, including N. farcinica (59) (92)(93)(94)(95)(96)(97). Linezolid is given 600 mg twice a day and can be given either intravenously or orally.…”
Section: Linezolid Is An Oxazolidinone Antibiotic Which Is Gaining Momentioning
confidence: 99%
“…Fifteen cases of nocardiosis treated with linezolid have been published to date (Table 1) [6][7][8][9][10][11][12][13][14][15]. Linezolid has a well-documented short-term adverse effect profile, with headache and diarrhea most commonly seen; however, its long-term safety profile ([28 days) has not been extensively studied.…”
Section: Discussionmentioning
confidence: 99%